Bavarian Nordic A/S (BVNKF)
OTC
Real-time Data
01:30 PM
Day's Range
27.5652 wk Range
27.56Overview - BVNKF - Bavarian Nordic A/S
Key Statistics
Valuation
Enterprise Value
37.17M
P/E (Trailing)
‪10.74‬
P/E (Forward)
‪12.62‬
PEG Ratio
‪-0.11‬
Price / Sales (TTM)
‪0.38‬
Price / Book
‪1.19‬
EV / EBITDA
‪0.13‬
Profitability
Gross Margin
‪44.82%‬
Profit Margin
‪24.33%‬
Operating Margin
‪36.80%‬
Return on Assets
‪5.00%‬
Return on Equity
‪12.21%‬
Ownership
Shares Outstanding
77.14M
Float
75.54M
Held by Insiders
‪0.01%‬
Held by Institutions
‪34.11%‬
Price stats
Beta
‪0.94‬
50-Day Avg
‪27.81‬
200-Day Avg
‪29.49‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - BVNKF - Bavarian Nordic A/S
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - BVNKF - Bavarian Nordic A/S
About
Bavarian Nordic A/S is a Danish biotechnology company specializing in the research, development, manufacturing, and commercialization of innovative vaccines based on viral vector technologies. Headquartered in Hellerup, Denmark, with manufacturing facilities in Denmark and Switzerland, and R&D sites in Germany plus…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
